Our Approach
Bioconjugation provides a powerful approach for developing new therapeutics, diagnostic reagents, and research tools. While the concept is straightforward, the process is inherently complex, requiring precise manipulation of delicate biomolecules using specialized crosslinkers and conjugation chemistries in aqueous environments.
CellMosaic® has established a robust intellectual property portfolio, proprietary technologies, advanced conjugation processes, and manufacturing know-how that enable us to develop innovative bioconjugation products and services. We work with our customers through several complementary business models to accelerate their research, product development, and commercialization.
- Fee-for-Service
Using established conjugation chemistries, clinically validated linkers, and CellMosaic's proprietary manufacturing processes, we provide standard and customized bioconjugation solutions without requiring customers to license our technologies. Services include Routine Synthesis™, custom bioconjugation, process development, scale-up, contract manufacturing (CDMO), bioanalytical services, biopurification, and bioassays. - Personalized Conjugation Kits (PerKit®)
For standardized bioconjugation processes that use customer-supplied starting materials, we develop and commercialize Personalized Conjugation Kits (PerKit®), enabling customers to prepare high-quality bioconjugates conveniently in-house. - Reagents and Bioconjugates
Frequently requested chemicals, linkers, labeled biomolecules, and bioconjugates developed through our service business are commercialized as reagent products, providing researchers with convenient access to high-quality materials. - Strategic Partnerships and Collaborative Development
We collaborate with pharmaceutical, biotechnology, and diagnostic companies to develop next-generation bioconjugates based on CellMosaic's proprietary AqT® Technologies. For partnership opportunities involving AqT® therapeutics and collaborative development, please visit AqT® Therapeutics.